Everything Innovation. Everything New Jersey.
Follow us and stay connected.
New steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight
The U.S. Food and Drug Administration released a suite of guidances to continue to encourage innovative approaches to the development of digital health tools, and to ensure the agency’s approach to overseeing these technologies advances along with it. We believe that an appropriate regulatory framework that takes into account the realities of how technology advances plays a crucial role in the efficient development of digital health technologies. Read more here.
Do not miss a single innovative moment and sign up for our newsletter!